Skip to main content

Table 1 Preoperative characteristics of patients who underwent trabeculectomy, Snellen acuity and MD change, and 3rd to 4th year follow-up cataract surgery cases

From: Biodegradable collagen matrix implant versus mitomycin-C in trabeculectomy: five-year follow-up

 

MMC group

OLO group

P

Gender (M/F), N°

11/9

12/8

1.0a

Age, yrs. (mean ± SD)

63.2(7.2)

65.8(6.4)

0.234b

Right/left eyes, N°

7/13

11/9

0.340a

Type of glaucoma (POAG/PEXG), N°

12/8

13/7

1.0a

Preoperative IOP,

mmHg (mean ± SD)

26.7(5.2)

27.3(6.0)

0.736b

Baseline CDVA, decimal notation

0.8 (±0.33)

0.75 (±0.31)

0.624

Endpoint CDVA, decimal notation

0.8 (±0.40)

0.8 (±0.35)

1.0

Baseline MD,

dB (mean ± SD)

-7.80(4.57)

-7.41(5.35)

0.805b

Endpoint MD,

dB (mean ± SD)

-7.60(4.3)

-7.50(5.6)

0.949b

Preoperative medications,

N° (mean ± SD)

2.5(0.3)

2.6(0.2)

0.222b

Duration of preoperative antiglaucoma therapy,

yrs. (mean ± SD)

5.7(1.8)

6.3(1.4)

0.246b

Cataract surgery cases

3 (15 %)

2 (10 %)

1.0

  1. aChi square test or Fisher exact test, as needed; bindependent Student t test;
  2. MMC = Mitomycin-C; OLO = Ologen; SD = standard deviation;
  3. POAG = primary open angle glaucoma; PEXG = pseudoexfoliation glaucoma; CDVA = Corrected Distance Visual Acuity; MD = Humphrey Visual Field Analyzer Mean deviation.